Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEUROTECH INTERNATIONAL LIMITED Capital/Financing Update 2021

Apr 22, 2021

65449_rns_2021-04-22_dbbd04f5-c612-49b7-a7e2-b47c433da760.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

Update Summary

Entity name

NEUROTECH INTERNATIONAL LIMITED

Announcement Type

Update to previous announcement

Date of this announcement

Thursday April 22, 2021

Reason for update to a previous announcement

Application for quotation of the Shares the subject of this Appendix 3B, to satisfy the requirements under section 723(3)(a) of the Corporations Act, per the Prospectus dated 19 April 2021.

These securities are now subject to Shareholder approval, as a result the proposed issue date has now changed.

Refer to next page for full details of the announcement

Proposed issue of securities

1 / 6

Proposed issue of securities

Part 1 - Entity and announcement details

==> picture [21 x 22] intentionally omitted <==

1.1 Name of +Entity

NEUROTECH INTERNATIONAL LIMITED

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

1.2 Registered Number Type

ABN

Registration Number

73610205402

1.3 ASX issuer code

NTI

1.4 The announcement is

==> picture [8 x 9] intentionally omitted <==

Update/amendment to previous announcement

1.4a Reason for update to a previous announcement

Application for quotation of the Shares the subject of this Appendix 3B, to satisfy the requirements under section 723(3)(a) of the Corporations Act, per the Prospectus dated 19 April 2021.

These securities are now subject to Shareholder approval, as a result the proposed issue date has now changed.

1.4b Date of previous announcement(s) to this update

Tuesday March 9, 2021

1.5 Date of this announcement

Thursday April 22, 2021

1.6 The Proposed issue is:

==> picture [8 x 8] intentionally omitted <==

A placement or other type of issue

Proposed issue of securities

2 / 6

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

Part 7 - Details of proposed placement or other issue

Part 7A - Conditions

7A.1 - Are any of the following approvals required for the placement or other type of issue? +Security holder approval Court approval Lodgement of court order with +ASIC ACCC approval FIRB approval Another approval/condition external to the entity Yes

7A.1a Conditions

Approval/Condition Date for determination Is the date estimated or ** Approval
+Security holder approval Friday May 7, 2021 actual? received/condition met?
Actual No

Comments

Please note the issue of these securities is subject to Shareholder approval at the upcoming General Meeting scheduled for the 7th of May 2021.

Part 7B - Issue details

Is the proposed security a 'New Will the proposed issue of this class' (+securities in a class that is +security include an offer of not yet quoted or recorded by ASX) attaching +securities? or an 'Existing class' (additional No securities in a class that is already quoted or recorded by ASX)? Existing class

Details of +securities proposed to be issued

ASX +security code and description

NTI : ORDINARY FULLY PAID

Number of +securities proposed to be issued

1,000,000

Reason for the update of 'Maximum Number of +securities proposed to be issued'

Offer price details

Proposed issue of securities

3 / 6

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

Are the +securities proposed to be issued being issued for a cash consideration? No

Please describe the consideration being provided for the +securities

CannaPacific to be issued 1,000,000 Shares on receipt of an Office of Drug Control permit for the production of NTI cannabis strains for clinical trials. Refer ASX Release of 9 March 2021.

Please note the issue of these securities is subject to Shareholder approval at the upcoming General Meeting scheduled for the 7th of May 2021.

Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities 0.063000

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Yes

Is the proposed security a 'New Will the proposed issue of this class' (+securities in a class that is +security include an offer of not yet quoted or recorded by ASX) attaching +securities? or an 'Existing class' (additional No securities in a class that is already quoted or recorded by ASX)? Existing class Details of +securities proposed to be issued

ASX +security code and description NTI : ORDINARY FULLY PAID Number of +securities proposed to be issued 1,000,000 Reason for the update of 'Maximum Number of +securities proposed to be issued' Offer price details Are the +securities proposed to be issued being issued for a cash consideration? No

Proposed issue of securities

4 / 6

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

Please describe the consideration being provided for the +securities

CannaPacific to be issued 1,000,000 Shares within 5 business days of the delivery of the first harvest of dried flower or by 1 August 2021 whichever occurs first. Refer ASX Release of 9 March 2021.

Please note the issue of these securities is subject to Shareholder approval at the upcoming General Meeting scheduled for the 7th of May 2021.

Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities

0.063000

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Yes

Part 7C - Timetable

7C.1 Proposed +issue date

Friday July 30, 2021

Part 7D - Listing Rule requirements

7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? Yes

7D.1a Date of meeting or proposed meeting to approve the issue under listing rule 7.1

Friday May 7, 2021

7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No

7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules? No

7D.4 Will any of the +securities to be issued be subject to +voluntary escrow? No

Part 7E - Fees and expenses

7E.1 Will there be a lead manager or broker to the proposed issue? No

Proposed issue of securities

5 / 6

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

7E.2 Is the proposed issue to be underwritten? No

7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue

Part 7F - Further Information

7F.01 The purpose(s) for which the entity is issuing the securities

Refer ASX Release of 9 March 2021

7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds? No

7F.2 Any other information the entity wishes to provide about the proposed issue

Proposed issue of securities

6 / 6